Skip to main content
OpenTrials
Completed

NCT Number: NCT02969460

Neurotrack Virtual Cognitive Health Study

The Neurotrack Virtual Cognitive Health Study is a 12-month long, prospective study that aims to evaluate the impact of the Neurotrack Virtual Cognitive Health Coaching Program on cognitive ability, anxiety and depression, and lifestyle behaviors for individuals who show signs of subjective cognitive decline.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Subjective Cognitive Decline

Age range

60 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Evidation Health

San Mateo, California, 94401, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 60-75
  • Individuals who show signs of subjective cognitive decline (assessed by scoring ≥ 1 on the Subjective Cognitive Decline [Short Form] Questionnaire and endorsing the Personal Worry Item on the questionnaire)
  • Have the ability to make and receive phone calls
  • Have the ability to send and receive text messages
  • Access to a desktop computer, video-teleconferencing and reliable internet connection
  • Motivated to use a daily coaching program

Exclusion criteria

  • Significant history of mental illness, substance abuse, learning disability, or neurologic conditions
  • History of dementia
  • Ophthalmologic/visual problems that prevent individual from viewing a computer screen at a normal distance (e.g., legal blindness, detached retinas, occlusive cataracts)
  • Currently participating in a formal cognitive-training coaching program
  • Currently pregnant

Treatment and study plan

Neurotrack Virtual Cognitive Health Program

Behavioral

Primary outcomes

  1. RBANS score

    Time frame: week 24

    Repeatable Battery for the Assessment of Neuropsychological Status total score

  2. RBANS score

    Time frame: week 52

    Repeatable Battery for the Assessment of Neuropsychological Status total score

Secondary outcomes

  1. PHQ-9

    Time frame: week 24

    Patient-health questionnaire 9-item scale

  2. PHQ-9

    Time frame: week 52

    Patient-health questionnaire 9-item scale

  3. GAD-7

    Time frame: week 24

    Generalized anxiety disorder 7-item scale

  4. GAD-7

    Time frame: week 52

    Generalized anxiety disorder 7-item scale

Sponsors and collaborators

Lead sponsor

Evidation Health

Industry

Collaborators

  • Neurotrack

Registry information

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Nov 21, 2016
Registry last updated
Oct 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.